Zimbabwe has turned down a significant US healthcare agreement valued at $367m (£272m) spanning five years over Washington's request for sensitive information.
This rejection became public after a internal memorandum from December was disclosed, revealing that Head of State Emmerson Mnangagwa felt the arrangement was "unbalanced".
A government representative has since stated that the United States was demanding access to biological samples for scientific study and commercial gain while was not willing to share the benefits from future medical innovations.
"We must now begin the challenging and unfortunate task of ending our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the United States had furnished over $1.9bn in health funding to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has called for further negotiations to reach a deal agreeable to both sides so the country's vital HIV treatment initiative can proceed.
Wider Implications
This rejection follows a comparable case in neighbouring Kenya, where a high court halted a related health funding agreement following legal challenges were filed about the safety of citizens' health data.
Since returning to the presidency last year, US President Donald Trump has drastically cut foreign aid and shut down the US Agency for International Development (USAID).
The agency had managed aid for the US government, but Trump claimed its expenditure was "inefficient" and his government was pursuing direct bilateral agreements to enhance transparency and accountability.
As per reports, Sixteen nations in Africa have so far signed similar agreements, constituting more than $18.3bn in new funding.
Details of the Declined Deal
This assistance for Zimbabwe would have funded "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this collaboration might have yielded immense advantages for Zimbabwean communities, especially the 1.2 million men, women and children currently on HIV treatment via American-funded initiatives," Tremont commented.
However, official spokesman Nick Mangwana argued the arrangement was "unequal".
"Zimbabwe was being asked to surrender its genetic material and health information over an extended period, without any corresponding guarantee of access to any scientific breakthroughs – like new medicines or tests – that might be developed from that provided information," his statement read.
"In essence, our country would supply the raw materials for scientific discovery with no certainty that the resulting innovations would be available to our citizens should a future pandemic arise."
National Interest and Global Health
Mangwana further pointed out that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one deals were disrupting frameworks previously established through the international health agency.
The spokesperson gave as an example its Pandemic Benefit-Sharing system designed to deal with future pandemics.
"This system is designed to ensure that when a country provides its samples, the resulting advantages – including medicines and cures – are distributed fairly, not commercialised exclusively by those with the resources to create them."
These objections regarding the US deal "should not be misconstrued as hostility towards the US," he added.
"We are open to continued discussions with our US partners on how subsequent co-operation might be arranged in a manner that respects the independence and dignity of both nations."
Medical Community Reaction
A leading public health body expressed it understood the government's concerns, but suggested that negotiations must proceed given that much of the nation's HIV programmes relied on foreign aid.
"If specific concerns arise, such as those relating to data governance or implementation frameworks, these can often be resolved via detailed discussion and mutually agreed protections," it commented.
The halted deal underscores the complex debate between receiving much-needed foreign assistance and safeguarding local interests in an increasingly interconnected world.